Recruiting studies: Ldrt

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC
Phase 2 · 2 location(s) · Sun Yat-sen University · NCT07325539 LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
Phase 1 · 2 location(s) · Daping Hospital and the Research Institute of Surgery of the · NCT06848465 Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced
Phase 2 · 6 location(s) · Sichuan University · NCT06121505 Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC
Phase 1/Phase 2 · 1 location(s) · Sichuan University · NCT06217757 Investigation of the Clinical Efficacy of Low-dose Ionizing Radiation in the Treatment of Osteoarthritis
NA · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT05887284 Immunophenotyping From Blood of Patients Suffering From Chronic Degenerating Joint Diseases and Receiving LDRT
Phase N/A · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT02653079 LDRT and Chemoimmunotherapy in NPC With Liver Metastasis
Phase 2 · 8 location(s) · Hunan Cancer Hospital · NCT06788002 Low-Dose Radiotherapy for Alzheimer's Disease
Phase 1/Phase 2 · 1 location(s) · Evan Thomas · NCT07693140 Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer
Phase 1 · 1 location(s) · Sichuan University · NCT06431685 Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors
Phase 1 · 1 location(s) · Sichuan University · NCT06349837 SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06323239 LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study
Phase 1/Phase 2 · 1 location(s) · Zhejiang Provincial People's Hospital · NCT07312422 Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radi
Phase 2 · 1 location(s) · Sichuan University · NCT06610734

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.